Business Segments (Tables)

9 Months Ended

Dec. 31, 2025

The tables below summarize information about our reportable segments.


	Three Months Ended December 31, 2025
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Total segment revenues*	$	235,697	$	47,747	$	283,444
Cost of sales	105,002		21,073		126,075
Gross profit	130,695		26,674		157,369
Advertising and marketing	32,686		7,369		40,055
Contribution margin	$	98,009	$	19,305	$	117,314
Other operating expenses					34,823
Operating income					$	82,491
* Intersegment revenues of $1.2 million were eliminated from the North American OTC Healthcare segment.


	Nine Months Ended December 31, 2025
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Total segment revenues*	$	679,031	$	128,057	$	807,088
Cost of sales	299,528		58,281		357,809
Gross profit	379,503		69,776		449,279
Advertising and marketing	93,673		20,020		113,693
Contribution margin	$	285,830	$	49,756	$	335,586
Other operating expenses					101,669
Operating income					$	233,917
* Intersegment revenues of $2.3 million were eliminated from the North American OTC Healthcare segment.


	Three Months Ended December 31, 2024
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Total segment revenues*	$	238,934	$	51,383	$	290,317
Cost of sales	108,067		21,201		129,268
Gross profit	130,867		30,182		161,049
Advertising and marketing	30,995		6,950		37,945
Contribution margin	$	99,872	$	23,232	$	123,104
Other operating expenses					31,142
Operating income					$	91,962
* Intersegment revenues of $0.9 million were eliminated from the North American OTC Healthcare segment.


	Nine Months Ended December 31, 2024
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Total segment revenues*	$	711,061	$	130,183	$	841,244
Cost of sales	321,408		55,383		376,791
Gross profit	389,653		74,800		464,453
Advertising and marketing	99,637		19,082		118,719
Contribution margin	$	290,016	$	55,718	$	345,734
Other operating expenses					97,387
Operating income					$	248,347
* Intersegment revenues of $2.5 million were eliminated from the North American OTC Healthcare segment.

The tables below summarize information about our segment revenues from similar product groups.


	Three Months Ended December 31, 2025
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Analgesics	$	26,735	$	1,298	$	28,033
Cough & Cold	22,992		6,335		29,327
Women's Health	51,817		5,948		57,765
Gastrointestinal	44,237		25,217		69,454
Eye & Ear Care	35,214		3,386		38,600
Dermatologicals	27,580		2,058		29,638
Oral Care	23,501		3,083		26,584
Other OTC	3,621		422		4,043

Total segment revenues	$	235,697	$	47,747	$	283,444


	Nine Months Ended December 31, 2025
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Analgesics	$	81,225	$	4,473	$	85,698
Cough & Cold	56,817		18,802		75,619
Women's Health	154,051		16,668		170,719
Gastrointestinal	134,346		57,092		191,438
Eye & Ear Care	92,382		12,703		105,085
Dermatologicals	88,224		7,219		95,443
Oral Care	62,694		10,359		73,053
Other OTC	9,292		741		10,033

Total segment revenues	$	679,031	$	128,057	$	807,088


	Three Months Ended December 31, 2024
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Analgesics	$	29,314	$	1,668	$	30,982
Cough & Cold	22,984		6,347		29,331
Women's Health	53,686		4,439		58,125
Gastrointestinal	42,521		26,469		68,990
Eye & Ear Care	38,895		6,783		45,678
Dermatologicals	28,546		2,109		30,655
Oral Care	19,869		3,211		23,080
Other OTC	3,119		357		3,476

Total segment revenues	$	238,934	$	51,383	$	290,317


	Nine Months Ended December 31, 2024
(In thousands)	North American OTC Healthcare		International OTC Healthcare		Consolidated
Analgesics	$	83,472	$	4,025	$	87,497
Cough & Cold	60,999		18,304		79,303
Women's Health	158,490		14,560		173,050
Gastrointestinal	128,719		58,347		187,066
Eye & Ear Care	118,354		18,240		136,594
Dermatologicals	93,789		6,076		99,865
Oral Care	58,241		9,696		67,937
Other OTC	8,997		935		9,932

Total segment revenues	$	711,061	$	130,183	$	841,244

Prestige Consumer Healthcare Inc. 10-Q